Topical Corticosteroids (e.g., Clobetasol Propionate)

Treatment for Vitiligo

Typical Dosage: Apply thin film once or twice daily for 2-3 months, then 2-3 times per week

Effectiveness
55%
Safety Score
35%
Clinical Trials
200
Participants
10K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
35
DangerousModerateSafe
Treatment Details
Dosage Range
Apply thin film once or twice daily for 2-3 months, then 2-3 times per week
Time to Effect
3-6 months
Treatment Duration
3-6 months continuous, then intermittent
Evidence Quality
HIGH
Number Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$200
Side Effect Mgmt:$100
Total Annual:$450
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$4,500/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$1,000
Cost per Remission
$5,625
Topical Corticosteroids (e.g., Clobetasol Propionate) Outcomes

for Vitiligo

Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+45%
Remission Rate
+8%
Common Side Effects
Skin atrophy
+15%
Telangiectasias
+8%
Acne
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov